Get the app
US › Healthcare

Lite Strategy, Inc. (LITS)

US · Healthcare · Biotechnology

$1.04+1.96%
Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-23.7M
EPS
$-0.66

Key statistics

Market cap
$37.1M
Forward P/E
4.6
P/B
0.65
Book value
$1.62
EPS (TTM)
$-1.95
52-week high
$2.97
52-week low
$0.69
50-day MA
$0.99
200-day MA
$1.14
Beta
0.04

Shareholding

Insiders
1.16%
Institutions
17.31%

Largest institutional holders

FundStake
Renaissance Technologies Corp5.47%
Vanguard Capital Management, LLC3.27%
RLH Capital LLC2.53%
Two Sigma Investments LLC1.75%
Geode Capital Management, LLC1.26%
Citadel Advisors Llc1.12%
Marshall Wace Asset Management Ltd1.05%
Vanguard Fiduciary Trust Co0.61%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lite Strategy, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.